Growing community of inventors

Beijing, China

Fangbin Han

Average Co-Inventor Count = 5.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Fangbin HanXichen Lin (1 patent)Fangbin HanHui Lei (1 patent)Fangbin HanYongHui Wang (1 patent)Fangbin HanSongwen Lin (1 patent)Fangbin HanQinghua Meng (1 patent)Fangbin HanHeng Xu (1 patent)Fangbin HanChongqin Yi (1 patent)Fangbin HanJing Tao (1 patent)Fangbin HanYonghui Wang (1 patent)Fangbin HanHui Lei (1 patent)Fangbin HanFangbin Han (2 patents)Xichen LinXichen Lin (22 patents)Hui LeiHui Lei (15 patents)YongHui WangYongHui Wang (9 patents)Songwen LinSongwen Lin (6 patents)Qinghua MengQinghua Meng (6 patents)Heng XuHeng Xu (6 patents)Chongqin YiChongqin Yi (1 patent)Jing TaoJing Tao (1 patent)Yonghui WangYonghui Wang (1 patent)Hui LeiHui Lei (5 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Glaxo Group Limited (1 from 1,169 patents)

2. Peking University (1 from 614 patents)

3. Pkucare Pharmaceutical R & D Center (1 from 1 patent)

4. Pku Healthcare Industry Group Co., Ltd. (1 from 1 patent)


2 patents:

1. 10005731 - Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases

2. 9902709 - Polysubstituted pyridine compound, preparation method, use and pharmaceutical composition

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/18/2026
Loading…